Pyxis Oncology, Inc.
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targ…
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Pyxis Oncology, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
Competitor | Private? | Source | Accuracy | Country | City |
---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. | FMP | High | United States | Burlingame | |
PDS Biotechnology Corporation | FMP | High | United States | Florham Park | |
ZyVersa Therapeutics, Inc. | FMP | High | United States | Weston | |
Elevation Oncology, Inc. | FMP | High | United States | New York | |
HOOKIPA Pharma Inc. | FMP | High | United States | New York | |
Zura Bio Limited | FMP | High | United States | San Diego | |
eFFECTOR Therapeutics, Inc. | FMP | High | United States | Solana Beach | |
X4 Pharmaceuticals, Inc. | FMP | High | United States | Boston | |
Inozyme Pharma, Inc. | FMP | High | United States | Boston | |
Terns Pharmaceuticals, Inc. | FMP | High | United States | Foster City | |
Icosavax, Inc. | FMP | High | United States | Seattle | |
Ocean Biomedical, Inc. | FMP | High | United States | Providence |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
Subsidiary | Private? | Country | City |
---|---|---|---|
- | - | - | - |